Understanding the link between the overexpression of HSP90 and cancer is crucial to finding better cancer treatments by exploiting the differences between normal and tumor cells in terms of HSP90 mRNA and protein induction, protein activation, and the number of post-translational modification (PTM) sites. The gene discussed is HSP90AB1; the disease is cancer.